Prescription Drug Policy, Drug Pricing & Aduhelm With Rachel Sachs
Listen to Health Affairs Forefront Editor Chris Fleming and Rachel Sachs from the Washington University in St. Louis discuss developments relating to the controversial Alzheimer’s drug Aduhelm and other prescription drug issues.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
While COVID-19 shallowed many headlines in the health care space, a lot of movement was made in various health policy areas, including prescription drug pricing.
On today's episode of Health Affairs This Week, Rachel Sachs, the Treiman Professor of Law at the Washington University in St. Louis, joins the program with Health Affairs Forefront Editor Chris Fleming to discuss Aduhelm and drug pricing.
The two discuss Rachel's latest Health Affairs Forefront article (formerly known as Health Affairs Blog) and review what happened in the prescription drug space last year and preview what to watch in 2022.
Related Links:
- Prescription Drug Policy: The Year In Review, And The Year Ahead (Health Affairs Forefront)
- The FDA's Approval Of Aduhelm: Potential Implications Across A Wide Range Of Health Policy Issues And Stakeholders (Health Affairs Forefront)
- Podcast: Drug Pricing On The Agenda For Massive Infrastructure Bill (Health Affairs This Week)
Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast